BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 6328529)

  • 1. RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day.
    Gaillard RC; Riondel A; Muller AF; Herrmann W; Baulieu EE
    Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3879-82. PubMed ID: 6328529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis].
    Gaillard RC; Herrmann W
    Ann Endocrinol (Paris); 1983; 44(5):345-6. PubMed ID: 6675522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
    J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new steroid analog RU 486 inhibits glucocorticoid action in man.
    Bertagna X; Bertagna C; Luton JP; Husson JM; Girard F
    J Clin Endocrinol Metab; 1984 Jul; 59(1):25-8. PubMed ID: 6327758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of anti-progesterones as a medical IUD.
    Nieman LK; Loriaux DL
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):609-16. PubMed ID: 3233821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Termination of very early pregnancy by RU 486--an antiprogestational compound.
    Kovacs L; Sas M; Resch BA; Ugocsai G; Swahn ML; Bygdeman M; Rowe PJ
    Contraception; 1984 May; 29(5):399-410. PubMed ID: 6744860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL; Sweeting VM; Hillier H; Baird DT
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility control in women: results with RU 486 by the end of 1985.
    Baulieu E
    J Steroid Biochem; 1986 Nov; 25(5B):847-51. PubMed ID: 3807366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifertility actions of the progesterone antagonist RU 486 include direct inhibition of placental hormone secretion.
    Das C; Catt KJ
    Lancet; 1987 Sep; 2(8559):599-601. PubMed ID: 2887889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy termination with a high and medium dosage regimen of RU 486.
    Shoupe D; Mishell DR; Brenner PF; Spitz IM
    Contraception; 1986 May; 33(5):455-61. PubMed ID: 3757511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose and time dependent rise of plasma cortisol following administration of mifepristone in early pregnancy.
    Thong KJ; Brooks AN; Baird DT
    Br J Obstet Gynaecol; 1993 Sep; 100(9):880-2. PubMed ID: 8218022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient inhibition of RU 486 antiglucocorticoid action by dexamethasone.
    Raux-Demay MC; Pierret T; Bouvier d'Yvoire M; Bertagna X; Girard F
    J Clin Endocrinol Metab; 1990 Jan; 70(1):230-3. PubMed ID: 2152931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional status of the pituitary-adrenal axis during treatment of RU486 for termination of early pregnancy in combination with PGs in Chinese women.
    Yang XL; Wu XR
    Adv Contracept; 1989 Mar; 5(1):31-9. PubMed ID: 2551132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiprogesterone steroid RU 486: a short pharmacological and clinical review, with emphasis on the interruption of pregnancy.
    Garfield RE; Baulieu EE
    Baillieres Clin Endocrinol Metab; 1987 Feb; 1(1):207-21. PubMed ID: 3297023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endocrine effects of long-term treatment with mifepristone (RU 486).
    Lamberts SW; Koper JW; de Jong FH
    J Clin Endocrinol Metab; 1991 Jul; 73(1):187-91. PubMed ID: 1646217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.